Cargando…
Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
The Amyloid Hypothesis states that the cascade of events associated with Alzheimer's disease (AD)—formation of amyloid plaques, neurofibrillary tangles, synaptic loss, neurodegeneration, and cognitive decline—are triggered by Aβ peptide dysregulation (Kakuda et al., 2006, Sato et al., 2003, Qi-...
Autores principales: | Tate, Barbara, McKee, Timothy D., Loureiro, Robyn M. B., Dumin, Jo Ann, Xia, Weiming, Pojasek, Kevin, Austin, Wesley F., Fuller, Nathan O., Hubbs, Jed L., Shen, Ruichao, Jonker, Jeff, Ives, Jeff, Bronk, Brian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536039/ https://www.ncbi.nlm.nih.gov/pubmed/23320246 http://dx.doi.org/10.1155/2012/210756 |
Ejemplares similares
-
Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models
por: Loureiro, Robyn M, et al.
Publicado: (2013) -
Natural Product and Natural Product-Derived Gamma Secretase Modulators from Actaea Racemosa Extracts
por: Findeis, Mark A., et al.
Publicado: (2015) -
Gamma-secretase: from pathogenesis to therapeutics
por: Li, Yueming
Publicado: (2012) -
Gamma secretase inhibitors of Notch signaling
por: Olsauskas-Kuprys, Roma, et al.
Publicado: (2013) -
Endogenous and exogenous regulation of gamma-secretase
por: Li, Yueming
Publicado: (2013)